Efficacy and Safety of Azelaic Acid (AzA) Gel 15% in the Treatment of Post-Inflammatory Hyperpigmentation and Acne: A 16-Week, Baseline-Controlled Study

June 2011 | Volume 10 | Issue 6 | Original Article | 586 | Copyright © June 2011

Leon H. Kircik, MD

  1. Kligman AM, Shelley WB. An investigation of the biology of the human sebaceous gland. J Invest Dermatol. 1958;30(3):99-125.
  2. Pochi PE, Strauss JS. Sebaceous gland activity in black skin. Dermatol Clin. 1988;6(3):349-351.
  3. Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med. 1993;20;328(20):1438-1443.
  4. Draelos Z, Kayne AL. Implications of azelaic acid's multiple mechanisms of action: Therapeutic versatility. Poster 443. Paper presented at: American Academy of Dermatology 66th Annual Meeting 2008; San Antonio, TX.
  5. Passi S. Pharmacology and pharmacokinetics of azelaic acid. Rev Contemp Pharmacother. 1993;4:441-447.
  6. Thiboutot D. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol. 2008;7(1):13-16.
  7. Davis EC, Callender VD. A review of acne in ethnic skin: Pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol. 2010;3(4):24-38.
  8. Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009;28(2):77-85.


Leon H. Kircik, MDPhysicians Skin Care1169 Eastern Parkway, Suite 2310Louisville, KY 40217Phone: (502) 456-2783Fax: (502) 456-2728